| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D261-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-42 |
| filingDate |
1990-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
1991-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0378134-A3 |
| titleOfInvention |
Use of a glycine b partial agonist as an antipsychotic |
| abstract |
A class of Glycine B partial agonists is ndescribed for use for treatment of psychosis. nPreferred Glycine B partial agonists include namino-isoxazolidone compounds such as D-cycloserine nand its prodrugs. |
| priorityDate |
1989-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |